LOINC Code 72309-8: NPM1 gene c.960insCCTG transcript/control transcript Molgen (Bld/Tiss) [# ratio]
72309-8 is a LOINC code used to identify NPM1 gene c.960insCCTG transcript/control transcript Molgen (Bld/Tiss) [# ratio] in laboratory and clinical observation data. You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges. LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component NPM1 gene.c.960insCCTG transcript/control transcript. It is commonly used with the system or sample type Bld/Tiss.
What is this code?
LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component NPM1 gene.c.960insCCTG transcript/control transcript. It is commonly used with the system or sample type Bld/Tiss.
When is it used?
- Used in lab systems, EHRs, and clinical data exchange.
- May identify a test, observation, survey item, or clinical document request rather than a diagnosis.
- Status: ACTIVE
- Order vs observation: Both
- Method: Molgen
What it does not mean
- The code identifies the observation or test, not the actual result.
Key facts
- NPM1 gene c.960insCCTG transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
- NPM1 gene.c.960insCCTG transcript/control transcript
- The quantification of NPM1 mutation D (c.960insCCTG) transcripts are compared to a control gene (e.g. ABL1) by real-time PCR (RT-qPCR). NPM1 primers and probes spanning exons 11 and 12 may be used to detect quantify the NPM1 mutation transcripts. Results are based on the normalized copy number [NPM1 mut D copy number/ABL1 copy number) x 100]. This test is based on, but not limited to, IPSOGEN'S NPM1-B/D MutaQuant Kit, which is used as research tool (as of 2012) for the quantification of NPM1-D transcripts in samples previously identified as carrying the NPM1 mutation D. The results are used to monitor the decrease of NPM1 mutD expression after treatment.
- ABL; ABL1; ABL1 transcript; B23; Blood; control gene; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; NPM; NPM1 gene mut D; Nucleolar phosphoprotein b23; nucleophosmin (nucleolar phosphoprotein B23, numatrin); Numatrin; Number ratio; PCR; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue
Where you may see this code
You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges.
Common synonyms
Frequently asked questions
About this content
This page is prepared by HealthAssure's clinical team using official coding standards from LOINC. AI tools assist with drafting explanations, which are then reviewed and verified by healthcare professionals for accuracy. This content is for informational purposes and does not replace professional medical advice. Meet our team.